Product Name: EIF2AK3 Antibody
Species Reactivity: Human
Tested Applications: IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 125 kDa
Immunogen: This EIF2AK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 73-102 amino acids from the N-terminal region of human EIF2AK3.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 313516-66-4
Product: T0070907
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Eukaryotic translation initiation factor 2-alpha kinase 3, PRKR-like endoplasmic reticulum kinase, Pancreatic eIF2-alpha kinase, HsPEK, EIF2AK3, PEK, PERK
Accession NO.: Q9NZJ5
Protein Ino: 296439367
Official Symbol: EIF2AK3
Geneid: 9451
Background: The protein encoded by this gene phosphorylates the alphasubunit of eukaryotic translation-initiation factor 2 (EIF2),leading to its inactivation, and thus to a rapid reduction oftranslational initiation and repression of global proteinsynthesis. It is a type I membrane protein located in theendoplasmic reticulum (ER), where it is induced by ER stress causedby malfolded proteins. Mutations in this gene are associated withWolcott-Rallison syndrome.
PubMed ID:http://aac.asm.org/content/39/7/1569.abstract
